Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

Vezics

Financiado

Cerrado

Highly efficient scalable chromatography platform for high quality exosome isol...

Highly efficient scalable chromatography platform for high quality exosome isolation There is enormous interest in using exosomes in the diagnosis and monitoring of cancer and other diseases, as well as their use as therapeutical tools. These cell-derived vesicles that are present in most bodily fluids are increas... ver más

31/05/2019

Vivoscreen Kft.

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

VIVOSCREEN KUTATASFEJLESZTESI KORLATOLT FELEL... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2019-05-31

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 5 años

0% 70% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

Vivoscreen Kft.

50.00K€ | Lider

ARCELORMITTAL ESPANA

254.81K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 4 meses Fecha Inicio: 2019-01-28
Fecha Fin: 2019-05-31

Líder del proyecto

VIVOSCREEN KUTATASFEJLESZTESI KORLATOLT FELEL... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto There is enormous interest in using exosomes in the diagnosis and monitoring of cancer and other diseases, as well as their use as therapeutical tools. These cell-derived vesicles that are present in most bodily fluids are increasingly considered the future of biomedicine. However, in terms of clinical applications, we are far from realising exosomes’ full potential. The greatest barrier is the lack of dependable protocols for their isolation. Vivoscreen is developing a novel platform for exosome isolation based on size exclusion chromatography (SEC) and immune affinity chromatography (IAC). Capitalising on very promising research results, the Vezics platform intends to offer all the advantages of SEC and IAC, while eliminating its disadvantages with regards to exosome isolation. The Vezics platform utilizes SEC as a first stage for exosome isolation. SEC media are selected according to the properties of the input material. The resulting EV-rich fractions are further purified by (IAC) on columns built for specific scientific needs. As high quality, by-product free isolation of exosomes is a prerequisite for all exosome applications, we expect our development to have a considerable positive impact across the entire spectrum; from research through diagnostic to therapeutic use of exosomes. This is a high risk / high reward project targeting an emerging market segment with extremely high growth potential. This proposal aims a Phase 1 feasibility study to better understand the risks and opportunities involved in this exciting venture. Our proposal was previously submitted to the SME Instrument and received 12.97 points. We hope that in the current proposal we managed to clarify key aspects of our approach to be found worthy for support. Since our last submission, we continued with the development and have built the functional prototype of the Vezics system. Thus, parallel to the feasibility study we can start its experimental validation and refinement as well.

Conecta tu I+D

Entra hoy

Forgot your password?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores